[144] Cellebrite DI Ltd. Warrants SEC Filing

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBTW) Form 144 notice shows an intended sale of 6,847 common shares through Goldman Sachs & Co. LLC on 09/02/2025, with an aggregate market value of $112,016.92 and 239,470,062 shares outstanding. The shares were acquired as restricted stock units: 1,021 shares vested on 08/31/2023 and 5,826 on 08/31/2024. The filer also reported a prior sale of 24,190 shares on 06/09/2025 for gross proceeds of $402,037.80. The notice includes the filer’s representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Disclosure completeness: Filing provides acquisition dates, quantities, sale date, broker and gross proceeds for recent sale
• Source clarity: Securities were acquired as restricted stock units (compensation), reducing ambiguity about origin

Negative

• Insider selling: Recent and planned insider sales (24,190 sold on 06/09/2025 and 6,847 planned on 09/02/2025) may prompt investor questions about insider liquidity
• Limited context: Filing does not provide reasons for the sales or whether a trading plan was used

Insights

Securities Analyst

TL;DR: Insider intends to sell vested RSUs totaling 6,847 shares, following a larger sale in June; transaction size is small relative to shares outstanding.

The filing documents a planned Rule 144 sale of 6,847 common shares via Goldman Sachs on 09/02/2025, arising from RSU vesting in 2023 and 2024. The earlier sale of 24,190 shares generated $402,037.80; combined, these transactions indicate routine monetization of vested equity rather than a corporate event. Relative to the issuer's 239.47 million outstanding shares, the planned sale is immaterial in size, implying limited market impact. The notice includes the standard attestation regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Transactions appear to be personal RSU sales by an insider and include the required Rule 144 disclosures and attestations.

The filer discloses the source of the securities as compensation (restricted stock units) and provides acquisition dates and quantities that reconcile to the shares proposed for sale. The presence of a recent prior sale (24,190 shares) and this planned sale is consistent with periodic insider liquidity. The filing contains the mandatory certification about possession of material information, meeting Form 144 disclosure requirements. No governance issues or irregularities are evident from the provided data alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	6847	112016.92	239470062	09/02/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2023	Acquired as compensation -- Restricted Stock Units	Issuer			1021	08/31/2023	Compensation
Common	08/31/2024	Acquired as compensation -- Restricted Stock Units	Issuer			5826	08/31/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Aliazar Keinan 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	06/09/2025	24190	402037.8

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CLBTW disclose?

The Form 144 discloses a planned Rule 144 sale of 6,847 common shares on 09/02/2025 through Goldman Sachs, with aggregate market value $112,016.92, and a prior sale of 24,190 shares on 06/09/2025 for $402,037.80.

Where did the shares subject to the Form 144 come from?

The shares were acquired as compensation in the form of restricted stock units (RSUs): 1,021 shares on 08/31/2023 and 5,826 shares on 08/31/2024.

Who is the broker handling the proposed sale for CLBTW?

The filing names Goldman Sachs & Co. LLC as the broker for the planned sale.

How large is the planned sale relative to outstanding shares?

The planned sale of 6,847 shares is small relative to the reported 239,470,062 shares outstanding.

Does the Form 144 state whether the filer possesses material nonpublic information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.